结合珠蛋白,表型2-2,人血浆

np001089-250μg

250μg

≥95%(SDS-PAGE)

触珠蛋白2-2（Hp 2-2）在结合游离血红蛋白的三种触珠蛋白表型中是最无效的，因此其抗氧化作用不如Hp 1-1。Hp 2-2与肾功能衰竭、家族性癫痫、高血压、动脉粥样硬化和冠心病有关。表型2-2的个体血浆中触珠蛋白浓度最低。SDS-PAGE没有可见的α-1轻链，由经美国食品药品监督管理局批准的测试显示对HBsAg、抗-HCV、抗-HBc无反应且对抗-HIV 1和2呈阴性的血浆制备。产品是实验室试剂，不得用于人类或任何药物目的。仅供研究使用。 Haptoglobin 2-2 (Hp 2-2) is the least effective of the three haptoglobin phenotypes in binding free hemoglobin and therefore provides less antioxidant benefits than Hp 1-1. Hp 2-2 is associated with renal failure, familial epilepsy, hypertension, atherosclerosis and coronary heart diseases. Individuals who are phenotype 2-2 have the lowest concentration of haptoglobin in plasma. no visible alpha-1 light chain by SDS-PAGE，Prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.products are laboratory reagents and are not to be administered to humans or used for any drug purpose. For research use only. Ref:Smithies,

Hp2-2:170,000-900,000